3673
-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
International Journal of Chronic Obstructive Pulmonary Disease
(637,084) Views
Editor in Chief Dr Richard E Russell
1178-2005(R)
Adherence to disease management programs in patients with COPDJohnson George, David CM Kong, Kay Stewart
Future therapeutic treatment of COPD: Struggle between oxidants and cytokines
Willem I de Boer, Hongwei Yao, Irfan Rahman
Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review
Katayoon Bahadori, J Mark FitzGerald
Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease
Xavier Busquets, Niall G MacFarlane, Damià Heine-Suñer, Montse Morlá, Laura Torres-Juan, et al
Editorial: Reference values in lung function testing: All for one and one for all? || FREE PAPER ||
Brendan G Cooper
Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
Arnt-Ove Hovden, Rebecca Jane Cox, Lars Reinhardt Haaheim
Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections
F Braido, F Tarantini, V Ghiglione, G Melioli, G W Canonica
Pulmonary hypertension and chronic cor pulmonale in COPD
Adil Shujaat, Ruth Minkin, Edward Eden
Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease
Biswajit Chakrabarti, Peter MA Calverley, Peter DO Davies
Potential therapeutic applications of hyaluronan in the lung
Jerome O Cantor
Measurement of the acute inflammatory response to walking exercise in COPD: effects of pulmonary rehabilitation
Jane Canavan, Rachel Garrod, Johanna Marshall, David Jackson, Paula Ansley, Andy Jewell
Improvements in exercise capacity during a 4-weeks pulmonary rehabilitation program for COPD patients do not correspond with improvements in self-reported health status or quality of life
Einar Haave, Michael E Hyland, Harald Engvik
Factors contributing to muscle wasting and dysfunction in COPD patients
Rob CI Wüst, Hans Degens
New insights on COPD imaging via CT and MRI
N Sverzellati, F Molinari, T Pirronti, L Bonomo, P Spagnolo, M Zompatori
Effect of change of reference standard to NHANES III on interpretation of spirometric ‘abnormality’
Akshay Sood, Beth K Dawson, Joseph Q Henkle, Patricia Hopkins-Price, Clifford Qualls
Factors affecting health status in COPD patients with co-morbid anxiety or depression
Minna J Hynninen, Ståle Pallesen, Inger Hilde Nordhus
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD
Helen Ilumets, Paula Rytilä, Ingel Demedts, Guy G Brusselle, Anssi Sovijärvi, et al
Volumetric capnography and chronic obstructive pulmonary disease staging
Pablo V Romero, Benigno Rodriguez, Daniela de Oliveira, L Blanch, Federico Manresa
Development and results of the Spanish registry of patients with alpha-1-antitrypsin deficiency
Beatriz Lara, Cristian de la Roza, Sara Vilà, Rafael Vidal, Marc Miravitlles
Plasma homocysteine is elevated in COPD patients and is related to COPD severity
Terence AR Seemungal, Johanna Cho Fook Lun, Gershwin Davis, Carlos Neblett, Nkhabe Chinyepi, et al
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
Marc Miravitlles
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
